Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP292429.RAu7hPbUjRvNEsIg0rAXgw4_T_0qnrUIez-c1HyMBPEpo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP292429.RAu7hPbUjRvNEsIg0rAXgw4_T_0qnrUIez-c1HyMBPEpo130_assertion type Assertion NP292429.RAu7hPbUjRvNEsIg0rAXgw4_T_0qnrUIez-c1HyMBPEpo130_head.
- NP292429.RAu7hPbUjRvNEsIg0rAXgw4_T_0qnrUIez-c1HyMBPEpo130_assertion description "[Combination of NPM-ALK repression and CD30 ligand leads to significantly increased tumor cell growth inhibition compared with one method alone, suggesting its potential application for ALCL-specific cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292429.RAu7hPbUjRvNEsIg0rAXgw4_T_0qnrUIez-c1HyMBPEpo130_provenance.
- NP292429.RAu7hPbUjRvNEsIg0rAXgw4_T_0qnrUIez-c1HyMBPEpo130_assertion evidence source_evidence_literature NP292429.RAu7hPbUjRvNEsIg0rAXgw4_T_0qnrUIez-c1HyMBPEpo130_provenance.
- NP292429.RAu7hPbUjRvNEsIg0rAXgw4_T_0qnrUIez-c1HyMBPEpo130_assertion SIO_000772 16982741 NP292429.RAu7hPbUjRvNEsIg0rAXgw4_T_0qnrUIez-c1HyMBPEpo130_provenance.
- NP292429.RAu7hPbUjRvNEsIg0rAXgw4_T_0qnrUIez-c1HyMBPEpo130_assertion wasDerivedFrom befree-20150227 NP292429.RAu7hPbUjRvNEsIg0rAXgw4_T_0qnrUIez-c1HyMBPEpo130_provenance.
- NP292429.RAu7hPbUjRvNEsIg0rAXgw4_T_0qnrUIez-c1HyMBPEpo130_assertion wasGeneratedBy ECO_0000203 NP292429.RAu7hPbUjRvNEsIg0rAXgw4_T_0qnrUIez-c1HyMBPEpo130_provenance.